NCT04766502View on ClinicalTrials.gov

Bonds Between Circulating Tumoral ADN (ctDNA) and the Development of Peritoneal Carcinomatosis for Patients Under PIPAC

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

January 11, 2022

Primary Completion Date

December 10, 2024

Study Completion Date

January 7, 2025

Conditions
Peritoneal Carcinomatosis
Interventions
OTHER

Blood sample (20 ml) and EORTC QLQC30 survey

"Blood sample (20ml) will be taken before and 24h after PIPAC procedure~EORTC QLQC30 during pre operative consultation and at each post operative consultations"

Trial Locations (1)

Unknown

Institut de Cancérologie de Lorraine, Vandœuvre-lès-Nancy

All Listed Sponsors
lead

Institut de Cancérologie de Lorraine

OTHER